Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Votruba

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Neuroscience|January 29, 2016
A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual functionT G Smith, S Seto, P Ganne, et al.
Behavioral Sciences (Basel, Switzerland)|September 27, 2025
Why Motive Matters: The Appraisal of Criminal AimsKeelah E G Williams, Ashley M Votruba, Ross S Eagle
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 24, 1998
Dominant optic atrophy: exclusion and fine genetic mapping of the candidate gene, HRYM Votruba, A Payne, A T Moore, et al.
Vision Research|January 20, 1999
Colour discrimination ellipses in patients with dominant optic atrophyM P Simunovic, M Votruba, B C Regan, et al.
Eye (London, England)|March 8, 2014
Treatment strategies for inherited optic neuropathies: past, present and futureP Yu-Wai-Man, M Votruba, A T Moore, et al.
Free Radical Biology & Medicine|November 28, 2019
The ying and yang of idebenone: Not too little, not too much - cell death in NQO1 deficient cells and the mouse retinaC Varricchio, K Beirne, C Heard, et al.
Investigative Ophthalmology & Visual Science|February 27, 2001
The pupil in dominant optic atrophyF D Bremner, E A Tomlin, J Shallo-Hoffmann, et al.
Wiener Klinische Wochenschrift|October 18, 2001
Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trialV Teplan, O Schück, M Votruba, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 26, 1998
Clinical features in affected individuals from 21 pedigrees with dominant optic atrophyM Votruba, F W Fitzke, G E Holder, et al.
Psychological Science|March 8, 2012
Effects of symptom presentation order on perceived disease riskVirginia S Y Kwan, Sean P Wojcik, Talya Miron-Shatz, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Neuroscience|January 29, 2016
A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual functionT G Smith, S Seto, P Ganne, et al.
Behavioral Sciences (Basel, Switzerland)|September 27, 2025
Why Motive Matters: The Appraisal of Criminal AimsKeelah E G Williams, Ashley M Votruba, Ross S Eagle
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 24, 1998
Dominant optic atrophy: exclusion and fine genetic mapping of the candidate gene, HRYM Votruba, A Payne, A T Moore, et al.
Vision Research|January 20, 1999
Colour discrimination ellipses in patients with dominant optic atrophyM P Simunovic, M Votruba, B C Regan, et al.
Eye (London, England)|March 8, 2014
Treatment strategies for inherited optic neuropathies: past, present and futureP Yu-Wai-Man, M Votruba, A T Moore, et al.
Free Radical Biology & Medicine|November 28, 2019
The ying and yang of idebenone: Not too little, not too much - cell death in NQO1 deficient cells and the mouse retinaC Varricchio, K Beirne, C Heard, et al.
Investigative Ophthalmology & Visual Science|February 27, 2001
The pupil in dominant optic atrophyF D Bremner, E A Tomlin, J Shallo-Hoffmann, et al.
Wiener Klinische Wochenschrift|October 18, 2001
Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trialV Teplan, O Schück, M Votruba, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 26, 1998
Clinical features in affected individuals from 21 pedigrees with dominant optic atrophyM Votruba, F W Fitzke, G E Holder, et al.
Psychological Science|March 8, 2012
Effects of symptom presentation order on perceived disease riskVirginia S Y Kwan, Sean P Wojcik, Talya Miron-Shatz, et al.
Pageof 3